An observational study in Healthy and Traumatic Brain Injury, sponsored by Frederick Carrick, PhD, FACCN. Completed at 1 site in United States. Open to participants aged 14 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-27.
Sponsored by Frederick Carrick, PhD, FACCN · Observational
Traumatic brain injury (TBI) is a health issue impacting athletes and no clinical treatment protocol, other than rest, is yet established. The efficacy of a treatment protocol relies on objective, physiological measures of brain function and ultimately a quantification of injury severity.
The present study aims to assess neurophysiological markers of auditory and visual measures of brain function using the NeuroCatch Platform and eye-tracking technology, respectively. The current gold standard of TBI evaluation, including cognitive and balance assessments, will also be captured.
2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.
This study's enrollment of 52 is below the median of 100 across 690 observational studies indexed under Brain Injuries.
Browse Brain Injuries studies →This is the only study on the registry with Frederick Carrick, PhD, FACCN as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Up to 70 hockey players aged 14-25 years will be included in the study.
NeuroCatch Platform-Specific Inclusion Criteria
Exclusion Criteria:
NeuroCatch Platform-Specific Exclusion Criteria
During each study visit, the participants will undergo the following procedures: * NeuroCatch Platform (NCP) assessment (only if participant meets NCP-specific criteria) * RightEye's eye-tracking battery * Highmark Interactive's EQ application * Cambridge Brain Science's neuropsychological tests
Device: NeuroCatch Platform (NCP)
The NCP plays a proprietary 6-minute auditory stimulus sequence of tones and words that elicit involuntary evoked responses in the brain. Tone stimuli elicit N100 and P300 responses, and spoken word pairs elicit N400 responses. The NCP proprietary software identifies the latency and amplitude (timing and size) of three selected ERPs. Latency and amplitude values are reported as empirical (measured) values.
ERP response size
amplitude in microvolts
Time frame: 1 week
ERP response timing
latency in milliseconds
Time frame: 1 week
Eye-tracking: target accuracy
distance in millimeters for each eye
Time frame: 1 week
Eye-tracking: speed
degrees per second
Time frame: 1 week
Cognitive tests
Cognitive assessments will be captured using Cambridge Brain Sciences battery of neuropsychological tests (composite score) and Highmark Interactive's EQ app
Time frame: 1 year
Balance
Balance measured in seconds as captured by Highmark Interactive's EQ app
Time frame: 1 week
Trends between outcome measures and demographics will be explored
Demographics include age, concussion history, and handedness
Time frame: 1 year
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.